IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, today announces three new biopharma contracts and the appointment of Lammert Albers as Chief Business Officer effective immediately. The new contracts are: ·     A start up agreement with a new client for a new multi-study programme in Progressive Supranuclear Palsy (PSP), with […]